Sign In
Buy PETS
$1.78
-0.350 (-16.43%)
At Close: Jun 03, 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acqui
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
08:30am, Monday, 20'th Oct 2025
Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEW
PETMED REMINDER: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders
05:06pm, Wednesday, 15'th Oct 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acqui
PetMeds® Files Form 10-K for Fiscal 2025
04:15pm, Tuesday, 14'th Oct 2025
DELRAY BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange C
SAN FRANCISCO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company anno
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) on behalf of investors concerning
SAN FRANCISCO , Oct. 10, 2025 /PRNewswire/ -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company announ
SAN FRANCISCO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company anno
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 08'th Oct 2025
DELRAY BEACH, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS), today announced that on September 9, 2025, th
Pets at Home rallies, broker sticks to 'buy' rating despite last week's profit warning
09:30am, Monday, 22'nd Sep 2025
Analysts at Jefferies have clipped their price target for Pets at Home Group PLC (LSE:PETS), from 330p to 250p, after last week's profit warning. The American broker, nevertheless, is sticking with a
Bank cuts Pets at Home target after CEO exit and profit warning
08:05am, Friday, 19'th Sep 2025
Deutsche Bank has cut its price target on Pets at Home Group PLC (LSE:PETS) to 215p from 275p after the sudden departure of chief executive Lyssa McGowan and a downgrade to profit guidance. The retail
Pets at Home tumbles as CEO steps down alongside profit warning
03:47am, Thursday, 18'th Sep 2025
Pets at Home Group PLC (LSE:PETS) shares plunged 18% after the retailer issued a second profit warning of the year and said CEO Lyssa McGowan had left the business with immediate effect. With the�
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acquire
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
04:35pm, Tuesday, 19'th Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
Block & Leviton LLP is investigating PetMed Express (NASDAQ: PETS) for securities fraud. Investors who have lost money in PetMeds should contact the firm.
